Monterey Bio Acquisition Corporation (MTRY) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 30.19M |
| Enterprise Value | 30.04M |
| P/E Ratio | -25.14 |
| PEG Ratio | 0.43 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.62 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -23.62 |
| Fiscal Year | December 31, 2022 |
| Most Recent Quarter | June 30, 2023 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.06 |
| Return On Equity | -0.02 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -2.04M |
| EBITDA | -2.04M |
| Net Income | -1.27M |
| Diluted EPS | -0.44 |
| Total Cash | 539,786 |
| Total Cash/Share | 0.05 |
| Total Debt | 1.92M |
| Total Debt/Equity | 0 |
| Current Ratio | 0.23 |
| Book Value Per Share | 6.87 |
| 52-Week Change | 8.05 |
| 52-Week High | 12 |
| 52-Week Low | 10.21 |
| Moving Average 50 Days | 11.21 |
| Moving Average 200 Days | 11.03 |
| Average Volume | 3,449 |
| Shares Outstanding | 4.34M |
| % Held by Institutions | 44.79 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |